Dexlansoprazole Capsule, Delayed Release
Product Images NDC 49884-147

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dexlansoprazole (NDC 49884-147). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Dexlansoprazole Delayed Release Capsules 1)

Chemical structure diagram of dexlansoprazole, showing its molecular bonds and arrangement including heterocyclic and aromatic rings, sulfoxide group, and trifluoromethyl substituent.*

FDA Label Image

Figure 1 (Dexlansoprazole Delayed Release Capsules 2)

A line graph showing plasma concentration (ng/mL) over time (hours) for dexlansoprazole at doses of 30 mg and 60 mg. The graph includes two curves: a dashed line with triangle markers for 30 mg and a solid line with circle markers for 60 mg, each indicating plasma concentration changes up to 24 hours.*

FDA Label Image

Bottle Of 30s (60 mg)

Label of Dexlansoprazole Delayed-Release Capsules 60 mg by Par Pharmaceutical, containing 30 capsules. The label includes dosage form as delayed-release capsules, strength of 60 mg per capsule, and caution about FD&C Yellow No. 5 as an ingredient. Storage instructions and distributor/manufacturer details are also present.*

FDA Label Image

Bottle Of 90s (60 mg)

Dexlansoprazole Delayed-Release Capsules 60 mg dosage label from Par Pharmaceutical. The label states each capsule contains 60 mg of Dexlansoprazole as enteric-coated granules. The package contains 90 capsules and includes pharmacy dispensing instructions, a caution about FD&C Yellow No. 5 (tartrazine), storage conditions, and a barcode. The manufacturer is Par Formulations Private Limited, India, distributed by Par Pharmaceutical in the USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.